These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34747194)

  • 1. One year outcome and predictors of treatment outcome in central serous chorioretinopathy: Multimodal imaging based analysis.
    Arora S; Maltsev DS; Singh Randhir S; Sahoo NK; Jhingan M; Parmeshwarappa D; Arora T; Kulikov A; Iovino C; Zur D; Fainberg G; Ibrahim MN; Tatti F; Gujar R; Venkatesh R; Reddy N; Snehith R; Peiretti E; Lupidi M; Chhablani J
    Eur J Ophthalmol; 2022 Jul; 32(4):2319-2327. PubMed ID: 34747194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual acuity correlates with multimodal imaging-based categories of central serous chorioretinopathy.
    Arora S; Maltsev DS; Sahoo NK; Parameshwarappa DC; Iovino C; Arora T; Kulikov AN; Tatti F; Venkatesh R; Reddy NG; Pulipaka RS; Singh SR; Peiretti E; Chhablani J
    Eye (Lond); 2022 Mar; 36(3):517-523. PubMed ID: 34645969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    Lai FH; Ng DS; Bakthavatsalam M; Chan VC; Young AL; Luk FO; Tsang CW; Brelén ME
    Am J Ophthalmol; 2016 Oct; 170():91-99. PubMed ID: 27519561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Outcome During Eplerenone Therapy in Chronic Central Serous Chorioretinopathy:A Prospective, Open-Label Pilot Clinical Study.
    Rajesh B; Agrawal H; Peguda HK; Chhablani J
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jul; 49(7):479-486. PubMed ID: 30021034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser.
    Enders C; Lang GE; Mayer B; Werner JU
    Ophthalmologica; 2022; 245(1):59-68. PubMed ID: 34517369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
    van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.
    Dhurandhar DS; Singh SR; Sahoo NK; Goud A; Lupidi M; Chhablani J
    Br J Ophthalmol; 2020 Jul; 104(7):904-909. PubMed ID: 31563867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy.
    Ntomoka CG; Rajesh B; Muriithi GM; Goud A; Chhablani J
    Eye (Lond); 2018 Jun; 32(6):1079-1086. PubMed ID: 29429986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.
    van Rijssen TJ; van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1395-1402. PubMed ID: 29732468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the response to photodynamic therapy in patients with chronic central serous chorioretinopathy based on optical coherence tomography using deep learning.
    Fernández-Vigo JI; Gómez Calleja V; de Moura Ramos JJ; Novo-Bujan J; Burgos-Blasco B; López-Guajardo L; Donate-López J; Ortega-Hortas M
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103107. PubMed ID: 36070850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].
    Liu Y; Li L; Xu G; Wang W
    Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):328-34. PubMed ID: 27220704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Eplerenone in Chronic Central Serous Chorioretinopathy Refractory to Photodynamic Therapy.
    Karagiannis D; Parikakis E; Kontomichos L; Batsos G; Chatziralli I
    Semin Ophthalmol; 2019; 34(6):436-441. PubMed ID: 31309849
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravitreal Brolucizumab for Chronic Central Serous Chorioretinopathy without Choroidal Neovascular Membrane - a Pilot Study.
    Ramamurthy SR; Behera UC; Narula R; Sadda SR; Narayanan R
    Semin Ophthalmol; 2024 Nov; 39(8):615-622. PubMed ID: 38270124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central serous chorioretinopathy imaging biomarkers.
    Singh SR; Iovino C; Zur D; Masarwa D; Iglicki M; Gujar R; Lupidi M; Maltsev DS; Bousquet E; Bencheqroun M; Amoroso F; Lima LH; Padhy SK; Govindahari V; Chandra K; Souied EH; Rodriguez FJ; Daza LA; Rios HA; Cagini C; Peiretti E; Behar-Cohen F; Chhablani J
    Br J Ophthalmol; 2022 Apr; 106(4):553-558. PubMed ID: 33288526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy.
    Yasui A; Yamamoto M; Hirayama K; Shiraki K; Theisen-Kunde D; Brinkmann R; Miura Y; Kohno T
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):243-254. PubMed ID: 27497611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy.
    Sheptulin V; Purtskhvanidze K; Roider J
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2027-2034. PubMed ID: 30097783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthreshold laser compared to oral spironolactone for the treatment of chronic central serous chorioretinopathy: a retrospective study.
    Mercuri S; D'Alterio FM; Gallo B; Raslan W; Gupta A; Khairat N; Corazza P; Younis S
    Int Ophthalmol; 2024 Mar; 44(1):131. PubMed ID: 38478131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
    Son BK; Kim K; Kim ES; Yu SY
    Ophthalmologica; 2019; 241(2):105-115. PubMed ID: 30110697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.